Hisanori Hara

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Glycopyrronium is a once-daily long-acting muscarinic antagonist for the maintenance treatment of patients with chronic obstructive pulmonary disease. This study assessed the pharmacokinetics of inhaled glycopyrronium 50 µg once-daily for 14 days in healthy Chinese subjects. In this open-label study, 12 Chinese healthy subjects (six males and six females;(More)
  • 1